Shire’s Bet on NPS Pharma Pays Off with Natpara® Approval
By Heather Cartwright
Pharma Deals Review: Vol 2015 Issue 2 (Table of Contents)
Published: 3 Feb-2015
DOI: 10.3833/pdr.v2015.i2.2091 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Shire’s decision to buy rare disease specialist NPS Pharmaceuticals for approximately US$5...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS